1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow SMT: new trials by email Literature Review of SMT trials Research Report on SMT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% SMT + PE-A 5%, Standard Medical Treatment - Acute-On-Chronic Liver Failure | Phase 3 | Terminated | Instituto Grifols, S.A. | 274 | 2019-06-17 | 2026-06-04 |
| Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites Albutein 20%, SMT - Decompensated Cirrhosis and Ascites | Phase 3 | Completed | Grifols Therapeutics LLC | 410 | 2018-07-24 | 2025-06-06 |
Acute-On-Chronic Liver Failure (1) · Ascites (1)
Grifols Therapeutics LLC (1) · Instituto Grifols, S.A. (1)
Belgium (2) · France (2) · Germany (2) · Italy (2) · Spain (2) · United Kingdom (2) · United States (2) · Austria (1) · Bosnia and Herzegovina (1) · Bulgaria (1) · Canada (1) · Denmark (1) · Hungary (1) · Poland (1) · Portugal (1)
2016 (1)